Machine-learning algorithms tuned to detecting cancer DNA in the blood could pave the way for personalized cancer care.
copyright by www.the-scientist.com
Modern cancer medicine is hampered by two big challenges—detecting cancers when they are small and offering cancer patients personalized, dynamic cancer care. To find solutions, several academic labs and biotech firms are turning to artificial intelligence, working to develop machine-learning algorithms that could help decipher weak signals in the blood that can identify cancers at an early stage and indicate whether a cancer is responding to treatment in real time.
“You have to find this needle in a haystack . . . this very weak signal amongst all of the cacophony of everything else happening in the body,” says Dave Issadore , a bioengineer at Pennsylvania State University and founder of Chip Diagnostics, which is developing a machine-learning method to diagnose disease by sequencing extracellular vesicles’ cargo.
So far, machine-learning algorithms designed to detect minute quantities of tumor DNA in a blood sample—the goal of so-called liquid biopsies—have performed well in clinical validation studies, but no self-learning algorithm has yet been approved for clinical use. These have the potential to outperform imaging and tissue biopsies in detecting and monitoring cancers by looking for mutations in DNA, RNA, and proteins directly from the blood.
“I think the dream of liquid biopsy is to, A), detect cancer when there is very little of it, and, B) detect cancers during treatment,” says Dan Landau, a clinical oncologist and researcher at Weill Cornell Medical School in New York. However, in the both contexts, liquid biopsy techniques struggle to accurately detect cancer among the infinitesimally small quantities of tumor nucleic acids in the blood. Although the technique’s performance varies between cancer types, liquid biopsies so far have been able to detect cancer in around half of early-stage patients diagnosed through imaging, giving it a sensitivity of just 50 percent.
Image Credit: The Scientist
News This Week
Tiny particles called quantum dots reduce symptoms in mice primed to develop a type of Parkinson’s disease, and also block formation of the toxic protein clumps in Alzheimer’s. They could one day be a [...]
Physicist Seth Fraden is developing a new generation of machines modeled on living creatures. His latest invention might one day treat disease by swimming its way through our blood. As a kid, physicist Seth [...]
Richard Feynman gave his famous talk "There's Plenty of Room at the Bottom" (Original Transcript Available Here : http://muonray.blogspot.ie/2012/12/ri...) on December 29th 1959 at the annual meeting of the American Physical Society at [...]
Postnova Analytics has published a new application note that describes a new approach for analysis of titanium dioxide nanoparticles in commercial sunscreens. The technique, which combines Inverse Supercritical Fluid Extraction (I-SFE) and Miniaturized Asymmetrical [...]
Leave it to Richard Branson to find motivation to go to the gym in traveling to space. On Tuesday, a ship from Brason’s space flight company, Virgin Galactic, achieved supersonic speed in a test [...]
Machine-learning algorithms tuned to detecting cancer DNA in the blood could pave the way for personalized cancer care. copyright by www.the-scientist.com Modern cancer medicine is hampered by two big challenges—detecting cancers when they are [...]